Quiz - Medthority

1. How many men with metastatic castration-resistant prostate cancer (mCRPC) have at least one homologous recombination repair (HRR) gene mutation?

A. About 10%

B. Nearly a quarter

C. Up to a third

D. Approximately half

2. Current prostate cancer (PC) management guidelines that include HRR mutation testing generally agree on which recommendation?

A. All men with PC should consider tumor testing

B. All men with PC should consider germline testing

C. All men with metastatic PC should have germline testing

D. All men with metastatic PC should have tumor testing

3. Which of the following statements is correct?

A. Black patients have poorer survival outcomes than White patients both in clinical trials and in the real world

B. Black patients have similar survival outcomes to White patients in clinical trials, but poorer real-world survival

C. Black patients have similar survival outcomes to White patients both in clinical trials and in the real world

D. Black patients have better survival outcomes to White patients in clinical trials, and similar real-world survival

4. Which biopsy sample type is most likely to yield good next-generation sequencing results?

A. Well-preserved archival tissue samples

B. Newly obtained sample from primary tissue

C. Newly obtained sample from metastatic lymph node tissue

D. Any sample from prostate core needle biopsy